JZJ, MATW, IEF, THRX, TSEM, OSUR Are Seasonally Ripe To Go Up In the Next Five Weeks
January 8, 2013 / M2 PRESSWIRE / BUYINS.NET / www.squeezetrigger.com is monitoring the Seasonality of Lehman ABS Corp (NYSE:JZJ), Matthews International Corp (NASDAQ:MATW), iShares Barclays 7-10 Year Treasury Bond Fund (NYSE:IEF), THERAVANCE, INC. (NASDAQ:THRX), Tower Semiconductor Ltd (NASDAQ:TSEM), OraSure Technologies Inc (NASDAQ:OSUR) and each have a high seasonal probability to go Up in the next weeks. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. SqueezeTrigger.com is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at: http://www.squeezetrigger.com/services/strat/mh.php
The following stocks are expected to go Up:
Symbol Company Expected Return Odds By The Following Date JZJ Lehman ABS Corp 2.29% 88.89% (8 of 9) Tuesday, February 5th 2013 MATW Matthews International Corp 3.00% 100.00% (13 of 13) Wednesday, January 16th 2013 IEF iShares Barclays 7-10 Year Treasury Bond Fund 0.71% 90.00% (9 of 10) Monday, January 14th 2013 THRX THERAVANCE, INC. 7.35% 87.50% (7 of 8) Monday, January 14th 2013 TSEM Tower Semiconductor Ltd 4.33% 92.31% (12 of 13) Wednesday, January 9th 2013 OSUR OraSure Technologies Inc 2.69% 92.31% (12 of 13) Wednesday, January 9th 2013Lehman ABS Corp (NYSE:JZJ) - Lehman ABS Corp. 7.125% Corporate Backed Trust Certificates AT&T NoteBac.
Matthews International Corp (NASDAQ:MATW) - Matthews International Corporation operates as a designer, manufacturer, and marketer of memorialization products and solutions for the cemetery and funeral home industries in the United States, Mexico, Canada, Europe, Australia, and Asia. Its Cemetery Products segment provides cast bronze, granite, and other memorialization products; and bronze and aluminum architectural products, as well as builds mausoleums. The company s Funeral Home Products segment manufactures and distributes caskets; casket components; and other funeral home products, such as urns, jewelry, and stationery, as well as produces a range of wood, metal, and cremation caskets. The company's Cremation segment offers cremation systems, waste management/incineration systems, environmental and energy systems, service and supplies, crematory management/operations, cremation columbarium and niche units, and cremation urns and memorialization products. Its Graphics Imaging segment provides pre-press graphics services, printing plates, gravure cylinders, steel bases, embossing tools, special purpose machinery, engineering assistance, print process assistance, print production management, digital asset management, content management, and package design services primarily to the packaging and corrugated industries. The company s Marking and Fulfillment Systems segment offers a range of marking and coding equipment and consumables, industrial automation products, and order fulfillment systems used for identifying, tracking, picking, and conveying consumer and industrial products. Its Merchandising Solutions segment provides merchandising, retail graphics, and printing solutions for brand owners and retailers; and designs and manufactures merchandising displays and systems, as well as provides creative merchandising and marketing solutions. The company was founded in 1850 and is based in Pittsburgh, Pennsylvania..
iShares Barclays 7-10 Year Treasury Bond Fund (NYSE:IEF) - ISHARES LEHMAN 7-10.
THERAVANCE, INC. (NASDAQ:THRX) - Theravance, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of small molecule medicines primarily for therapeutic areas of respiratory diseases, bacterial infections, and central nervous system (CNS)/pain. The company offers VIBATIV, a bactericidal injectable antibiotic for the treatment of Gram-positive infections. Its principal development programs with GlaxoSmithKline plc include the RELOVAIR that has completed Phase 3 clinical studies for the treatment of patients with chronic obstructive pulmonary disease (COPD) or asthma; the LAMA/LABA combination, a Phase 3 program for patients with COPD; and the Bifunctional Muscarinic Antagonist-Beta2 Agonist (MABA) program that has completed Phase 2b study for the treatment of COPD. The company s principal development programs also comprise and the Peripheral Mu-Opioid Receptor Antagonist (P MA) program for the TD-1211 mu-opioid receptor designed to alleviate gastrointestinal side effects of opioid therapy without affecting analgesia. In addition, it develops TD-4208 that has completed Phase 2a single-dose COPD study; TD-1792, an antibiotic under clinical-stage for the treatment of serious infections caused by Gram-positive bacteria; MARIN program with compound TD-9855 under Phase 2 study for the treatment of attention-deficit/hyperactivity disorder; TD-5108, which has completed Phase 1 study for the treatment of Alzheimer s disease, and completed Phase 2 proof-of-concept study for the treatment of chronic idiopathic constipation(CIC); and TD-8954 that has completed single- and multiple-ascending dose Phase 1 studies for treatment of CIC. The company was formerly known as Advanced Medicine, Inc. and changed its name to Theravance, Inc. in April 2002. Theravance, Inc. was founded in 1996 and is headquartered in South San Francisco, California..
Tower Semiconductor Ltd (NASDAQ:TSEM) - Tower Semiconductor Ltd., an independent semiconductor foundry, manufactures analog intensive mixed-signal semiconductor devices in the United States, India, the Asia Pacific, Europe, and Israel. It produces integrated circuits (IC) using production processes, primarily based on third party designs and proprietary designs with geometries ranging from 1.0 to 0.095-micron, as well as provides design and technical services. The company also offers design enablement tools; and a range of customizable process technologies, including SiGe, BiCMOS, mixed-signal and RFCMOS, CMOS image sensor, power management, and non-volatile memory, as well as MEMS capabilities. Its ICs are used in a range of products in various markets, including consumer electronics, personal computers, communications, automotive, industrial, and medical device products. The company offers its foundry services to fabless semiconductor companies and independent device manufacturers. Tower Semiconductor Ltd. was founded in 1993 and is headquartered in Migdal Haemek, Israel..
OraSure Technologies Inc (NASDAQ:OSUR) - OraSure Technologies, Inc. develops, manufactures, markets, and sells oral fluid diagnostic products and specimen collection devices in the United States and internationally. Its products include OraQuick ADVANCE HIV-1/2, a point-of-care qualitative test for antibodies to the Human Immunodeficiency Virus (HIV) Type 1 and 2; OraQuick HCV, a point-of-care qualitative test for antibodies to the hepatitis C virus; OraSure QuickFlu Rapid Flu A&B Test, a point-of-care qualitative test for antibodies to influenza Types A and B, including H1N1 infections; OraSure, an oral fluid collection device for the detection of antibodies to HIV-1 in an oral fluid sample; and Intercept, an oral fluid collection device for oral fluid drugs of abuse testing in a laboratory setting. The company s products also comprise cryosurgical systems for the removal of common and plantar warts, and other benign skin lesions; Oragene DX, OMNIgene DISCOVER, ORAcollect, and Oragene DNA, which are non-invasive systems for the collection, stabilization, transportation, and storage of human DNA from saliva; OMNIgene DISCOVER, a non-invasive all-in-one system for the collection, stabilization, transportation, and storage of microbial DNA from saliva; and Performagene LIVESTOCK and Oragene ANIMAL systems for the collection, stabilization, transportation, and storage of livestock DNA from nasal samples. In addition, it sells immunoassay tests and reagents for insurance risk assessment, substance abuse testing, and forensic toxicology applications; an oral fluid Western blot HIV-1 confirmatory test; and Q.E.D. rapid point-of-care saliva alcohol test. The company sells its products to clinical laboratories, hospitals, clinics, community-based organizations and other public health organizations, distributors, government agencies, physicians offices, and commercial and industrial entities. OraSure Technologies, Inc. was founded in 1979 and is based in Bethlehem, Pennsylvania..
SqueezeTrigger.com has built a massive database that collects, analyzes and publishes multiple proprietary trading strategies that predict price moves in stocks, commodities and currencies. The data has then been integrated into an automated trading platform which can be used to connect to a live online broker and automate your trading of each of the strategies highlighted. It is extremely powerful with lightening fast execution at a very low price. Both the trading software and SqueezeTrigger data feed are available at http://www.squeezetrigger.com
www.squeezetrigger.com monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:
REGULATORY & COMPLIANCE NEWS
Friction Factor -- market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements".
RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO.
INVESTMENTS & TRADING
SqueezeTrigger -- 25 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.
Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.
Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.
Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.
Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.
GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.
About SQUEEZETRIGGER.COM
WWW.SQUEEZETRIGGER.COM is a service designed to help bonafide shareholders of publicly traded US companies fight short selling. SqueezeTrigger.com has built a proprietary database that uses Threshold list feeds and short sale time and sale data from NASDAQ, AMEX and NYSE to generate detailed and useful information to combat the short selling problem. For the first time, actual trade by trade data is available to the public that shows the attempted size, actual size, price and average value of short sales in stocks that have been shorted. This information is valuable in determining the precise point at which short sellers go out-of-the-money and start losing on their short trades.
SQUEEZETRIGGER.COM has built a massive database that collects, analyzes and publishes a proprietary SqueezeTrigger for each stock that has been shorted. The SqueezeTrigger database of nearly 2.5 billion short sale transactions goes back to January 1, 2005 and calculates the exact price at which the Total Short Interest is short in each stock. This data was never before available prior to January 1, 2005 because the Self Regulatory Organizations (primary exchanges) guarded it aggressively. After the SEC passed Regulation SHO, exchanges were forced to allow data processors like SqueezeTrigger.com to access the data.
The SqueezeTrigger database collects individual short trade data on over 7,000 NYSE, AMEX and NASDAQ stocks and general short trade data on nearly 8,000 OTCBB and PINKSHEET stocks. Each month the database grows by approximately 50,000,000 short sale transactions and provides investors with the knowledge necessary to time when to buy and sell stocks with outstanding short positions. By tracking the size and price of each montha'a"s short transactions, SQUEEZETRIGGER.COM provides institutions, traders, analysts, journalists and individual investors the exact price point where short sellers start losing money and a short squeeze can begin.
All material herein was prepared by SQUEEZETRIGGER.COM, based upon information believed to be reliable. The information contained herein is not guaranteed by SQUEEZETRIGGER.COM to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion.
Occassionally companies pay $995.00 to purchase data for information provided in reports issued by BUYINS.NET, a company affiliated with SQUEEZETRIGGER.COM. The data service can be cancelled at any time. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. SQUEEZETRIGGER.COM is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein. SQUEEZETRIGGER.COM will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market.
SQUEEZETRIGGER.COM and SQUEEZETRIGGER are intended for use by stock market professionals. As a member, visitor, or user of any kind, you accept full responsibilities for your investment and trading actions. The contents of SQUEEZETRIGGER.COM, including but not limited to all implied or expressed views, opinions, teachings, data, graphs, opinions, or otherwise are not predictions, warranty, or endorsements of any kind. Please seek stock market advice from the proper securities professional, or investment advisor.
By visiting SQUEEZETRIGGER.COM or using any data or services, you agree to assume full responsibility for the decisions or actions that you undertake. Global Automated Trading Systems, LLC, its owner(s), operators, employees, partners, affiliates, advertisers, information providers and any other associated person or entity, shall under no circumstances be held liable to the user and/or any third party for loss or damages of any kind, including but not limited to trading losses, lost trading opportunity, direct, indirect, consequential, special, incidental, or punitive damages. As a user, you agree that any damages collected shall not exceed the amount paid to SQUEEZETRIGGER.COM and/or its owners. As a website user, you agree that any and all legal matters of any kind are to be reviewed and handled in their entirety within the State of California only. By using the services of this website, you are consenting to the terms as outlined, and forfeit all legal jurisdictions in any other State.
Past performance is not a guarantee of future outcomes. Any and all examples are hypothetical and should not be considered a guarantee or endorsement of such trading activity. SQUEEZETRIGGER.COM does not take responsibility for problems of any kind, including but not limited to issues with operations, data accuracy or completeness, contacting issues, technical issues, and timeliness. SQUEEZETRIGGER.COM places great integrity on the data collected and distributed. This information is deemed reliable, but not guaranteed. All information and data is provided "as is" without warranty or guarantee of any kind.
Please seek investment and/or trading advice, council, information or services from a securities professional. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and SQUEEZETRIGGER.COM undertakes no obligation to update such statements.
This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected", "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies' annual report on Form 10-K or 10-KSB and other filings made by such company with the SEC.
Contact: Thomas Ronk, CEO www.squeezetrigger.com +1-800-715-9999 Tom@squeezetrigger.com
SqueezeTrigger is a registered trademark, Reg. No. 3,120,641